HB Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86M | Buy |
45,261
+6,502
| +17% | +$698K | 0.04% | 230 |
|
|
2025
Q1 | $3.91M | Buy |
38,759
+8,723
| +29% | +$880K | 0.03% | 260 |
|
|
2024
Q4 | $2.68M | Buy |
30,036
+1,676
| +6% | +$150K | 0.03% | 239 |
|
|
2024
Q3 | $2.38M | Buy |
28,360
+5,342
| +23% | +$448K | 0.03% | 251 |
|
|
2024
Q2 | $1.77M | Buy |
23,018
+3,219
| +16% | +$248K | 0.02% | 280 |
|
|
2024
Q1 | $1.36M | Buy |
19,799
+728
| +4% | +$49.9K | 0.02% | 304 |
|
|
2023
Q4 | $1.1M | Buy |
19,071
+404
| +2% | +$23.4K | 0.02% | 303 |
|
|
2023
Q3 | $986K | Buy |
18,667
+4,279
| +30% | +$226K | 0.02% | 295 |
|
|
2023
Q2 | $778K | Buy |
14,388
+1,048
| +8% | +$56.7K | 0.01% | 329 |
|
|
2023
Q1 | $667K | Buy |
13,340
+2,022
| +18% | +$101K | 0.01% | 356 |
|
|
2022
Q4 | $524K | Buy |
11,318
+5,041
| +80% | +$233K | 0.01% | 385 |
|
|
2022
Q3 | $243K | Buy |
+6,277
| New | +$243K | 0.01% | 486 |
|
|
2022
Q2 | – | Sell |
-7,161
| Closed | -$317K | – | 582 |
|
|
2022
Q1 | $317K | Buy |
+7,161
| New | +$317K | 0.01% | 437 |
|